Publication: Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.
dc.contributor.author | Iacoboni, Gloria | |
dc.contributor.author | Rejeski, Kai | |
dc.contributor.author | Villacampa, Guillermo | |
dc.contributor.author | van Doesum, Jaap A | |
dc.contributor.author | Chiappella, Annalisa | |
dc.contributor.author | Bonifazi, Francesca | |
dc.contributor.author | Lopez-Corral, Lucia | |
dc.contributor.author | van Aalderen, Michiel | |
dc.contributor.author | Kwon, Mi | |
dc.contributor.author | Martínez-Cibrian, Nuria | |
dc.contributor.author | Bramanti, Stefania | |
dc.contributor.author | Reguera-Ortega, Juan Luis | |
dc.contributor.author | Camacho-Arteaga, Lina | |
dc.contributor.author | Schmidt, Christian | |
dc.contributor.author | Marín-Niebla, Ana | |
dc.contributor.author | Kersten, Marie José | |
dc.contributor.author | Martin Garcia-Sancho, Alejandro | |
dc.contributor.author | Zinzani, Pier Luigi | |
dc.contributor.author | Corradini, Paolo | |
dc.contributor.author | van Meerten, Tom | |
dc.contributor.author | Subklewe, Marion | |
dc.contributor.author | Barba, Pere | |
dc.date.accessioned | 2023-05-03T13:32:52Z | |
dc.date.available | 2023-05-03T13:32:52Z | |
dc.date.issued | 2022 | |
dc.identifier.doi | 10.1182/bloodadvances.2021006922 | |
dc.identifier.essn | 2473-9537 | |
dc.identifier.pmc | PMC9631549 | |
dc.identifier.pmid | 35271707 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631549/pdf | |
dc.identifier.unpaywallURL | https://ashpublications.org/bloodadvances/article-pdf/6/12/3606/1902623/advancesadv2021006922.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/20251 | |
dc.issue.number | 12 | |
dc.journal.title | Blood advances | |
dc.journal.titleabbreviation | Blood Adv | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 3606-3610 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Antineoplastic Agents | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Immunotherapy, Adoptive | |
dc.subject.mesh | Lymphoma, Mantle-Cell | |
dc.subject.mesh | Neoplasm Recurrence, Local | |
dc.subject.mesh | Pyrimidines | |
dc.subject.mesh | Receptors, Chimeric Antigen | |
dc.title | Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 6 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1